NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Up 937.7% in December

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 594,600 shares, a growth of 937.7% from the November 30th total of 57,300 shares. Approximately 15.9% of the shares of the company are short sold. Based on an average trading volume of 384,900 shares, the days-to-cover ratio is presently 1.5 days.

NanoVibronix Price Performance

NanoVibronix stock traded up $0.05 during trading hours on Thursday, hitting $0.58. The company had a trading volume of 32,146 shares, compared to its average volume of 144,899. The firm has a 50-day moving average of $0.63 and a 200 day moving average of $0.65. The firm has a market cap of $2.19 million, a PE ratio of -0.48 and a beta of 1.61. NanoVibronix has a one year low of $0.46 and a one year high of $1.52.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.